[Daniel K. Donahue Tel 949.732.6500 Fax 949.732.6501 donahued@gtlaw.com August 9, 2012 Via Edgar Rufus Decker, Accounting Branch Chief Division of Corporation Finance 100 F Street, N.E. Re: Entertainment Gaming Asia Inc. Form 10-K for the Year Ended December 31, 2011 File No. 1-32161 Dear Mr. Decker: located in Hong Kong only to the extent of its audit work of a]
[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu President and Chief Executive Officer] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Chief Financial Officer]
[NOAHS LIMITED Tao Thomas Wu Chief Financial Officer STYLE="font-family:Times New Roman" SIZE="2">NOAHS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2012 SHANGHAI, CHINA August8, 2012 Noahs Limited (Noah or thempany) (NYSE: NOAH), the leading independent service provider focusing on distributing wealth management products to the high net worth population in China, today announced]
[Silicon Motion Announces Departure of Henry Chen as a Member of the Board of Directors Taipei, Taiwan, August 8, 2012 Silicon Motion Technology Corporation (NasdaqGS: SIMO) (Silicon Motion or the Company) announced today that Henry Chen resigned from the Companys Board of Directors, effective July 31, 2012. His replacement will be elected during the Companys upcoming annual shareholders meeting.] [Press Release issued by the Company on August 8, 2012. ILICON OTION]
[China Biologic Reports Financial Results for the 2Q12 Total Sales Up 21.1% to $50.5 Million Up 52.2% to $13.3 Million BEIJING, China August 9, 2012 Second Quarter 2012 Financial Highlights Total sales Gross profit Income from operations Net income attributable to the Company Non-GAAP adjusted net income attributable to the Company Mr. David (Xiaoying) Gao, Chairman and chief] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 9, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86-10-6698-3166 (Former name or former address,]
[NOAHS LIMITED Tao Thomas Wu Chief Financial Officer STYLE="font-family:Times New Roman" SIZE="2">NOAHS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2012 SHANGHAI, CHINA August8, 2012 Noahs Limited (Noah or thempany) (NYSE: NOAH), the leading independent service provider focusing on distributing wealth management products to the high net worth population in China, today announced]
[Silicon Motion Announces Departure of Henry Chen as a Member of the Board of Directors Taipei, Taiwan, August 8, 2012 Silicon Motion Technology Corporation (NasdaqGS: SIMO) (Silicon Motion or the Company) announced today that Henry Chen resigned from the Companys Board of Directors, effective July 31, 2012. His replacement will be elected during the Companys upcoming annual shareholders meeting.] [Press Release issued by the Company on August 8, 2012. ILICON OTION]
[China Biologic Reports Financial Results for the 2Q12 Total Sales Up 21.1% to $50.5 Million Up 52.2% to $13.3 Million BEIJING, China August 9, 2012 Second Quarter 2012 Financial Highlights Total sales Gross profit Income from operations Net income attributable to the Company Non-GAAP adjusted net income attributable to the Company Mr. David (Xiaoying) Gao, Chairman and chief] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 9, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86-10-6698-3166 (Former name or former address,]
[Part I – Financial Information Item 1. Financial Statements 1 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3. Quantitative and Qualitative Disclosures about Market Risk 39 Item 4. Controls and Procedures 40 Part II – Other Information Item 1. Legal Proceedings 40 Item 1A. Risk Factors 41 Item 2. Unregistered Shares of] [Certification of Chief Executive Officer I, Xiaobin Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2012 of Gulf Resources, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [Certification of Chief Financial Officer I, Min Li, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2012 of Gulf Resources, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350 AND EXCHANGE ACT RULES 13a-14(b) AND 15d-14(b) (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company. Dated: August 9, 2012 Xiaobin Liu Chief Executive Officer and President Dated: August 9, 2012 Min]
[FORM 10 - Q (Mark One) [X] For the quarterly period ended: June 30, 2012 [ ] For the transition period from _________________to________________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 (+86) 10-6598-3111 _____________________________________________________ Yes [X] No [ ] Yes [X]] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]
